PedAM
Pediatric Disease Annotations & Medicines
| Disease | hypoglycemia |
| Phenotype | |type 2 diabetes |
| Sentences | 135 |
| PubMedID- 23874102 | Fear and psychological discomfort were observed as important aggravating factors of hypoglycemia among patients with type 2 diabetes mellitus (table 3). |
| PubMedID- 21777428 | The primary cause of hypoglycemia among patients with type 2 diabetes is antihyperglycemic medications - in particular, those which raise insulin levels independently of blood glucose, such as sulfonylureas and insulin [6]. |
| PubMedID- 25678212 | Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials. |
| PubMedID- 23540483 | Aim: to ascertain the effect of five chronic diseases (joint disorder, respiratory disease, anaemia, malignancy, depression) and three chronically used drugs (non-steroid anti-inflammatory drugs [nsaids], corticosteroids, antidepressants) on treatment for hypoglycaemia in patients with type 2 diabetes. |
| PubMedID- 23043166 | Conclusions: insulins degludec and glargine administered once daily in combination with oads provided similar long-term glycemic control in insulin-naive patients with type 2 diabetes, with lower rates of nocturnal hypoglycemia with degludec. |
| PubMedID- 26229480 | hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the french health insurance database. |
| PubMedID- 25765720 | Objective: reported rates of hypoglycemia in patients with type 2 diabetes mellitus are lower with glimepiride as compared to glyburide. |
| PubMedID- 22018449 | Objective: we identified risk factors for hypoglycemia hospitalization in patients with type 2 diabetes treated with oral antidiabetic drugs (oads). |
| PubMedID- 26338288 | Risk factors associated with hypoglycemia in patients with type 2 diabetes include old age, long disease duration, low body mass index, high baseline glycated hemoglobin (hba1c), treatment with insulin and sulphonylurea, renal dysfunction, albuminuria, reduced level of low density lipoprotein cholesterol, low triglyceride and depression. |
| PubMedID- 24650952 | Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (getgoal-s). |
| PubMedID- 25917335 | hypoglycemia in type 2 diabetes--more common than you think: a continuous glucose monitoring study. |
| PubMedID- 22399700 | The strong blood glucose–lowering effects induced by exercise may be associated with an augmented risk of developing hypoglycemia in patients with advanced type 2 diabetes (31,32). |
| PubMedID- 25282010 | In trials in type 2 diabetes, rates of nocturnal hypoglycemia were lower with insulin degludec than with insulin glargine, and more flexible; once-daily dose timing was shown to be possible. |
| PubMedID- 25834461 | Nevertheless, there is concern regarding the potential for hypoglycemia in patients with type 2 diabetes treated with dpp-4 inhibitors and sulfonyulureas.28 this issue should be investigated in detail in a real clinical setting. |
| PubMedID- 26338296 | Identifying the worries and concerns about hypoglycemia in adults with type 2 diabetes. |
| PubMedID- 22454405 | Purpose: the purpose of this study was to examine the association between self-monitoring of blood glucose (smbg) and problem-solving skills in response to detected hyperglycemia and hypoglycemia among patients with type 2 diabetes. |
| PubMedID- 22115901 | Objective: to assess the effect of targeting intensive glycaemic control versus conventional glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial infarction, microvascular complications, and severe hypoglycaemia in patients with type 2 diabetes. |
| PubMedID- 21680984 | Iatrogenic hypoglycemia in patients with type 2 diabetes: comparison of insulin analog premixes and human insulin premixes. |
| PubMedID- 24147203 | Glucagon-like peptide-1 (glp-1) receptor agonists result in greater improvements in glycemic control than placebo and promote weight loss with minimal hypoglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 23067027 | Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues bid in outpatient settings. |
| PubMedID- 22563248 | Sulfonylurea therapy, which increases insulin output from the pancreas, is one of the key contributors to hypoglycemia in patients with type 2 diabetes who are early in the progression of the disease. |
| PubMedID- 23996548 | Aim: to assess in real life the rate of hypoglycemia during ramadan in patients with type 2 diabetes (t2dm) in france, according to their ongoing dual therapy of metformin-vildagliptin or metformin-sulfonylurea/glinide (is). |
| PubMedID- 22661969 | Furthermore, hypoglycemia in type 2 diabetes is associated with longer length of hospital stay, greater cost, and higher mortality during hospitalization (curkendall et al., 2009; turchin et al., 2009). |
| PubMedID- 22234990 | Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large us administrative claims database. |
| PubMedID- 24824197 | Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study. |
| PubMedID- 23497433 | Impaired symptomatic awareness is associated with a 6-fold and 9-fold increased risk of severe hypoglycemia in patients with type1 and type 2 diabetes respectively [8,20]. |
| PubMedID- 20649629 | Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using nph insulin or insulin glargine. |
| PubMedID- 22401876 | Insulinoma is rarely encountered as a cause of hypoglycemia in patients with type 2 diabetes. |
| PubMedID- 26113983 | By increasing glucosuria, sglt-2 inhibitors are associated with significant improvements of fasting hyperglycemia and hba1c concentration, and with low risk of hypoglycemia in patients with type 2 diabetes. |
| PubMedID- 23373726 | The risk of hypoglycaemia in type 2 diabetes has also been reported to be significantly lower with igf-1 than with conventional insulin therapy. |
| PubMedID- 22391950 | And, in particular,does resistance or endurance exercising bear a greater risk of hypoglycaemia in humans with type 2 diabetes on oral glucose-lowering drugs or on insulin? |
| PubMedID- 25349949 | Conclusion: depression in type 2 diabetes was closely associated with hyperglycemia and hypoglycemia, which might be partly mediated through poor treatment adherence. |
| PubMedID- 21838763 | The aim of the current review is to examine published evidence to achieve a synthesis of the scope and significance of the potential detriment caused by hypoglycaemia to individuals with type 2 diabetes. |
| PubMedID- 24437153 | [quality of life and problems posed by hypoglycemia in type 2 diabetes mellitus during oral hypoglycemic therapy]. |
| PubMedID- 24450135 | [case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product]. |